Nutrition is one of the most vital elements needed for maintaining health, management and prevention of various diseases. Nutritional support is given to people who are unable to get sufficient nourishment through diet (eating or drinking). Enteral feeding is the delivery of nutrients directly into the digestive tract through a tube. This tube is generally placed into the duodenum, jejunum or stomach through mouth, nose or through percutaneous route. Enteral feeding is used to feed individuals who are unable to get adequate diet through oral intake either from food or nutritional supplements, or patients who cannot eat/drink safely. The process of enteral feeding is commonly used in patients with dysphagia (impairment of drinking, eating, and/or swallowing). Increasing geriatric population and rising number of preterm births has led to the rise of patients requiring enteral feeding devices. In addition to this, high prevalence of chronic diseases, including diabetes, cancer, gastrointestinal diseases, and neurological disorders, coupled with rising need for patients’ ease throughout hospitalization, and recent technological innovations are some of the key factors fuelling global enteral feeding devices market growth.
Request Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/392
Strategic partnership and acquisitions among key players, launch and approval of novel products, and increasing prevalence of various chronic diseases such as cancer and gastrointestinal diseases is expected to boost global enteral feeding devices market growth over the forecast period. For instance, in 2015, Medtronic plc acquired Covidien and in 2014, Medela acquired the enteral feeding assets of Acacia, Inc., U.S.-based company, that designs and produces a line of high quality neonatal feeding devices. Such organic as well as inorganic strategies would support global enteral feeding devices market growth over the forecast period. Moreover, according to the American Cancer Society (ACS), around 17,650 new esophageal cancer cases in the U.S. are expected to be diagnosed (13,750 in men and 3,900 in women) by 2019. These factors are expected to support the global enteral feeding devices market growth over the forecast period.
Some of the major players operating in the global enteral feeding devices market include Halyard Health, Inc., Fresenius SE & Co. KGaA, Abbott Laboratories, B. Braun Melsungen AG, Medtronic Plc, Cook Medical, C. R. Bard, Inc., Nestle Health Science, Moog, Inc., and ConMed Corporation.
Ask For Discount Before Purchasing This Business Report @ https://www.coherentmarketinsights.com/insight/request-discount/392